Year |
Citation |
Score |
2014 |
Zeng C, Yi X, Zipris D, Liu H, Zhang L, Zheng Q, Malathi K, Jin G, Zhou A. RNase L contributes to experimentally induced type 1 diabetes onset in mice. The Journal of Endocrinology. 223: 277-87. PMID 25287058 DOI: 10.1530/Joe-14-0509 |
0.455 |
|
2013 |
Yi X, Zeng C, Liu H, Chen X, Zhang P, Yun BS, Jin G, Zhou A. Lack of RNase L attenuates macrophage functions. Plos One. 8: e81269. PMID 24324683 DOI: 10.1371/Journal.Pone.0081269 |
0.458 |
|
2013 |
Zhong B, Chennamaneni S, Lama R, Yi X, Geldenhuys WJ, Pink JJ, Dowlati A, Xu Y, Zhou A, Su B. Synthesis and anticancer mechanism investigation of dual Hsp27 and tubulin inhibitors. Journal of Medicinal Chemistry. 56: 5306-20. PMID 23767669 DOI: 10.1021/Jm4004736 |
0.511 |
|
2012 |
Yi X, Zhong B, Smith KM, Geldenhuys WJ, Feng Y, Pink JJ, Dowlati A, Xu Y, Zhou A, Su B. Identification of a class of novel tubulin inhibitors. Journal of Medicinal Chemistry. 55: 3425-35. PMID 22435708 DOI: 10.1021/Jm300100D |
0.478 |
|
2012 |
Zhong B, Cai X, Chennamaneni S, Yi X, Liu L, Pink JJ, Dowlati A, Xu Y, Zhou A, Su B. From COX-2 inhibitor nimesulide to potent anti-cancer agent: synthesis, in vitro, in vivo and pharmacokinetic evaluation. European Journal of Medicinal Chemistry. 47: 432-44. PMID 22119125 DOI: 10.1016/J.Ejmech.2011.11.012 |
0.493 |
|
2011 |
Zhong B, Cai X, Yi X, Zhou A, Chen S, Su B. In vitro and in vivo effects of a cyclooxygenase-2 inhibitor nimesulide analog JCC76 in aromatase inhibitors-insensitive breast cancer cells. The Journal of Steroid Biochemistry and Molecular Biology. 126: 10-8. PMID 21458568 DOI: 10.1016/J.Jsbmb.2011.03.018 |
0.456 |
|
Show low-probability matches. |